- Home
- ONCY vs ADAG Comparison
ONCY vs ADAG Comparison
Compare ONCY & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- ADAG
- Stock Information
- Founded
- ONCY 1998
- ADAG 2011
- Country
- ONCY Canada
- ADAG China
- Employees
- ONCY N/A
- ADAG N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- ADAG Health Care
- Exchange
- ONCY Nasdaq
- ADAG Nasdaq
- Market Cap
- ONCY 89.7M
- ADAG 84.4M
- IPO Year
- ONCY 1999
- ADAG 2021
- Fundamental
- Price
- ONCY $1.02
- ADAG $1.60
- Analyst Decision
- ONCY Strong Buy
- ADAG Strong Buy
- Analyst Count
- ONCY 5
- ADAG 3
- Target Price
- ONCY $5.00
- ADAG $7.67
- AVG Volume (30 Days)
- ONCY 948.7K
- ADAG 55.1K
- Earning Date
- ONCY 11-07-2025
- ADAG 08-12-2025
- Dividend Yield
- ONCY N/A
- ADAG N/A
- EPS Growth
- ONCY N/A
- ADAG N/A
- EPS
- ONCY N/A
- ADAG N/A
- Revenue
- ONCY N/A
- ADAG $103,204.00
- Revenue This Year
- ONCY N/A
- ADAG $7,411.34
- Revenue Next Year
- ONCY N/A
- ADAG $28.29
- P/E Ratio
- ONCY N/A
- ADAG N/A
- Revenue Growth
- ONCY N/A
- ADAG N/A
- 52 Week Low
- ONCY $0.33
- ADAG $1.30
- 52 Week High
- ONCY $1.51
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- ONCY 37.21
- ADAG 39.96
- Support Level
- ONCY $0.92
- ADAG $1.47
- Resistance Level
- ONCY $1.05
- ADAG $1.74
- Average True Range (ATR)
- ONCY 0.08
- ADAG 0.14
- MACD
- ONCY -0.02
- ADAG -0.02
- Stochastic Oscillator
- ONCY 25.00
- ADAG 33.33
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.